Leading the revolution in vaccine technology

Renowned scientists and entrepreneurs unite to create a unique platform for rapid development of highly versatile and efficient vaccines.

Learn More
Covid-19 Vaccine Laboratory

About us

LinKinVax is a French biotechnology startup that focuses on speeding up vaccine development by bringing together basic science and industrial processes.

Learn More

RESEARCH & DEVELOPMENT

The discovery of dendritic cells’ role in adaptative immunity system lead to a Nobel Prize in 2011.
Ten years of research later, 3 vaccines are entering clinical trial in 2021-2022. 

+
+

Press releases

June 21, 2021

Press release

Biotech start-up LinKinvax is created to accelerate the development, clinical trial and market access of a unique and innovative vaccine platform
See press release
May 26, 2021

Press release

LinKinVax-Labex VRI consortium secures 31 M€ in public funding to develop a booster vaccine against COVID-19
See press release

NEWS

September 1, 2021

A news from Nature : Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves…

CLICK HERE
PDF LINK
June 23, 2021

LinKinvax, biotech créée pour accélérer le développement et l’entrée en essai clinique d’une plateforme vaccinale unique et innovante

CLICK HERE
June 22, 2021

LinKinvax, une biotech créée pour accélérer le développement et l’entrée en essai clinique d’une plateforme vaccinale unique et innovante

CLICK HERE
May 26, 2021

La Tribune : Covid 19 en 24 heures

CLICK HERE
May 26, 2021

Capital : Vaccin Covid-19 : une société biotech française obtient un gros financement de l’Etat

CLICK HERE
February 25, 2021
AFP

Appel à des volontaires pour un essai de vaccin préventif anti-VIH

CLICK HERE
VIEW MORE

Interested in our project?

CONTACT US